YOLFTbeta
19

NOVAREX Co.Ltd

194700 · KQ · Consumer Defensive / Packaged Foods

8,560.00KRW-180.00 (-2.06%)

Price History

Full chart

Market Stats

Previous Close8,740.00
Open8,700.00
Day Range8,540.00 – 8,850.00
52-Week Range9,970.00 – 18,739.73
Volume26.94K
Market Cap184.65B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield3.91%
Beta0.28
50-Day Avg11,971.40
200-Day Avg13,625.05

About

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science Co., Ltd. and changed its name to NOVAREX Co.,Ltd. in November 2013. NOVAREX Co.,Ltd. was founded in 1995 and is headquartered in Cheongju-si, South Korea.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • Employees464
  • Headquarters80, Osongsaengmyeong 14-ro, Cheongju-si, South Korea, Korea
  • Websitehttps://www.novarex.co.kr

Financials

Income Statement

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue82.74B77.13B80.85B107.31B159.10B222.83B278.79B281.68B302.17B297.73B404.26B
Growth (%)--6.79%+4.83%+32.72%+48.26%+40.06%+25.11%+1.04%+7.28%-1.47%+35.78%
Cost of Revenue65.31B61.47B63.82B86.65B130.49B183.63B237.35B241.26B258.24B254.49B334.17B
Gross Profit17.43B15.65B17.03B20.66B28.62B39.20B41.44B40.42B43.93B43.23B70.09B
Gross Margin21.07%20.30%21.07%19.26%17.99%17.59%14.87%14.35%14.54%14.52%17.34%
Operating Expense6.22B5.38B7.12B9.59B12.31B12.21B11.43B15.39B18.46B20.12B27.04B
Operating Income11.22B10.27B9.91B11.07B16.31B26.99B30.01B25.03B25.47B23.11B43.05B
Operating Margin13.55%13.32%12.25%10.32%10.25%12.11%10.76%8.89%8.43%7.76%10.65%
EBITDA-------33.24B35.96B38.81B55.13B
EBITDA Margin-------11.80%11.90%13.04%13.64%
Net Income9.67B9.20B8.10B9.49B14.71B25.15B26.40B19.99B22.04B23.02B35.42B
Net Income Margin11.69%11.93%10.02%8.84%9.25%11.28%9.47%7.10%7.29%7.73%8.76%
R&D131.16M316.79M598.11M898.26M1.01B1.65B83.95M2.14B3.37B3.85B3.96B
R&D as % of Total Revenue0.16%0.41%0.74%0.84%0.63%0.74%0.03%0.76%1.12%1.29%0.98%
Interest Expense00000191.97M799.11M1.24B1.37B880.22M837.64M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.09%0.29%0.44%0.45%0.30%0.21%

Balance Sheet

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets56.24B60.21B71.80B106.32B154.37B215.50B254.63B270.58B264.73B289.61B359.55B
Total Liabilities19.93B15.59B19.92B27.40B62.58B99.89B114.96B89.21B64.32B69.35B104.91B
Total Equity36.31B44.62B51.88B78.93B91.79B115.61B139.67B181.12B200.23B219.26B253.12B
Cash15.31B16.02B21.72B35.59B29.52B31.86B19.17B27.02B30.23B31.05B49.60B
Total Debt----21.16B54.74B-----
Net Debt-----21.64B34.33B18.28B---

Cash Flow

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow8.72B7.38B10.62B7.44B-1.30B16.26B24.13B20.11B25.30B13.31B16.65B
Investing Cash Flow-2.27B-3.95B-5.29B-12.22B-22.40B-45.99B-34.06B-23.35B3.47B-7.42B-
Financing Cash Flow1.28B-1.23B-909.84M18.58B17.64B32.62B-2.89B11.18B-25.26B-5.39B-
Capital Expenditure2.38B3.36B4.85B8.99B20.93B40.41B37.40B16.12B8.72B6.91B10.47B
Free Cash Flow------24.23B-13.27B3.99B16.58B6.39B6.18B
Dividends Paid745.16M1.15B1.15B1.53B1.59B1.59B2.39B2.39B2.66B3.54B3.54B
FCF to OCF------149.02%-54.99%19.83%65.54%48.03%37.10%
Dividend Paid to FCF------6.56%-17.98%59.81%16.01%55.40%57.31%

Earnings

Report DateFeb 11, 2019May 15, 2019Aug 14, 2019Nov 12, 2019Feb 9, 2020May 11, 2020Aug 11, 2020Nov 10, 2020Feb 9, 2021May 11, 2021Aug 13, 2021Nov 11, 2021Mar 18, 2022May 16, 2022Aug 11, 2022Nov 14, 2022Mar 22, 2023May 15, 2023Jun 30, 2023Nov 29, 2023Mar 21, 2024May 14, 2024Jun 30, 2024Nov 27, 2024Mar 19, 2025May 14, 2025Aug 12, 2025Nov 12, 2025Mar 18, 2026May 12, 2026
EPS Estimate-----798.00--455.83---911.67455.83----------------
EPS Actual104.00344.00439.00247.79560.93383.00728.94398.36414.08476.95325.67335.98492.50455.83374.04351.00157.03242.42350.95376.12275.32210.95391.04182.63515.61402.03431.84690.01476.27805.59
Surprise------52.01%---9.16%----45.98%0.00%----------------
Timing--Pre-marketAfter-hours-After-hoursPre-marketAfter-hours-After-hours-Pre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap184.65B
Enterprise Value162.31B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.46
Price / Book0.67
Revenue (TTM)404.26B
Gross Profit (TTM)69.98B
EBITDA52.69B
Profit Margin8.76%
Operating Margin10.63%
Return on Equity15.15%
Return on Assets8.29%
Shares Outstanding17.75M
Shares Float10.66M
Beta0.28
Dividend Yield3.91%
Dividend Rate400.00
Payout Ratio20.29%

Dividends

20251×
400.00Dec 29, 2025
20241×
200.00Dec 27, 2024
20231×
200.00Dec 27, 2023
20221×
150.00Dec 28, 2022
20211×
147.00Dec 29, 2021
20201×
147.00Dec 29, 2020
20191×
98.00Dec 27, 2019
20181×
98.00Dec 27, 2018

Stock Splits

  • Aug 18, 20222:1
  • Jul 6, 20221799:1763